{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:39:09Z","timestamp":1788273549073,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2369-15-156","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T07:01:34Z","timestamp":1412060494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma"],"prefix":"10.1186","volume":"15","author":[{"given":"Liliane","family":"Hobeika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally E","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos Q","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"issue":"2","key":"846_CR1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1172\/JCI115629","volume":"89","author":"PW Sanders","year":"1992","unstructured":"Sanders PW, Booker BB: Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest. 1992, 89 (2): 630-10.1172\/JCI115629. doi:10.1172\/JCI115629","journal-title":"J Clin Invest"},{"key":"846_CR2","first-page":"460","volume":"110","author":"P Smolens","year":"1987","unstructured":"Smolens P, Barnes JL, Kreisberg R: Hypercalcemia can potentiate the nephrotoxicity of Bence Jones proteins. J Lab Clin Med. 1987, 110: 460-465.","journal-title":"J Lab Clin Med"},{"issue":"1","key":"846_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS, Fine PL, Stack JI, Kunis CL, Radhakrishnan J, Palecki W, Park J, Nasr SH, Hoh S, Siegel DS, D\u2019Agati VD: Toxic acute tubular necrosis following treatment with zoledronate. Kidney Int. 2003, 64 (1): 281-289. 10.1046\/j.1523-1755.2003.00071.x.","journal-title":"Kidney Int"},{"issue":"6","key":"846_CR4","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/10428190802023707","volume":"49","author":"ED Batts","year":"2008","unstructured":"Batts ED, Sanchorawala V, Hegerfeldt Y, Lazarus HM: Azotemia associated with use of lenalidomide in plasma cell dyscrasias. Leuk Lymphoma. 2008, 49 (6): 1108-1115. 10.1080\/10428190802023707. doi:10.1080\/10428190802023707","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"846_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/sj.ki.5000055","volume":"69","author":"CR Parikh","year":"2006","unstructured":"Parikh CR, Coca SG: Acute renal failure in hematopoietic cell transplantation. Kidney Int. 2006, 69 (3): 430-435. 10.1038\/sj.ki.5000055.","journal-title":"Kidney Int"},{"issue":"2","key":"846_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2215\/CJN.02070508","volume":"4","author":"S Changsirikulchai","year":"2009","unstructured":"Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR: Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009, 4 (2): 345-353. 10.2215\/CJN.02070508. doi:10.2215\/CJN.02070508","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"846_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4143\/crt.2008.40.4.211","volume":"40","author":"MK Choi","year":"2008","unstructured":"Choi MK, Hong JY, Jang JH, Lim HY: TTP-HUS associated with sunitinib. Cancer Res Treat. 2008, 40 (4): 211-213. 10.4143\/crt.2008.40.4.211. doi:10.4143\/crt.2008.40.4.211","journal-title":"Cancer Res Treat"},{"issue":"11","key":"846_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE: VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008, 358 (11): 1129-1136. 10.1056\/NEJMoa0707330. doi:10.1056\/NEJMoa0707330","journal-title":"N Engl J Med"},{"issue":"2","key":"846_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30 (2): 239-245. 10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"846_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.bmt.1701830","volume":"24","author":"P Iacopino","year":"1999","unstructured":"Iacopino P, Pucci G, Arcese W, Bosi A, Falda M, Locatelli F, Marenco P, Miniero R, Morabito F, Rossetti F, Sica S, Uderzo C, Bacigalupo A: Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Bone Marrow Transplant. 1999, 24 (1): 47-51. 10.1038\/sj.bmt.1701830.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"846_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/qjmed\/89.10.751","volume":"89","author":"MH Griffiths","year":"1996","unstructured":"Griffiths MH, Crowe AV, Papadaki L, Banner NR, Yacoub MH, Thompson FD, Neild GH: Cyclosporin nephrotoxicity in heart and lung transplant patients. Q J Med. 1996, 89 (10): 751-763. 10.1093\/qjmed\/89.10.751.","journal-title":"Q J Med"},{"issue":"6","key":"846_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.bmt.1702849","volume":"27","author":"V Roy","year":"2001","unstructured":"Roy V, Rizvi MA, Vesely SK, George JN: Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant. 2001, 27 (6): 641-646. 10.1038\/sj.bmt.1702849.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"846_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bmt.1701171","volume":"21","author":"G Lugassy","year":"1998","unstructured":"Lugassy G, Ducach A, Blumenthal R: Fatal chronic relapsing thrombotic thrombocytopenic purpura following autologous bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant. 1998, 21 (8): 859-860. 10.1038\/sj.bmt.1701171.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"846_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/sj.bmt.1700791","volume":"19","author":"E Ohno","year":"1997","unstructured":"Ohno E, Ohtsuka E, Iwashita T, Uno N, Ogata M, Kikuchi H, Nasu M: Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma. Bone Marrow Transplant. 1997, 19 (10): 1045-1047. 10.1038\/sj.bmt.1700791.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"846_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12185-008-0140-1","volume":"88","author":"R Morita","year":"2008","unstructured":"Morita R, Hashino S, Shirai S, Fujita N, Onozawa M, Kahata K, Kondo T, Imamura M, Asaka M: Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma. Int J Hematol. 2008, 88 (2): 248-250. 10.1007\/s12185-008-0140-1. doi:10.1007\/s12185-008-0140-1","journal-title":"Int J Hematol"},{"issue":"4","key":"846_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1445-5994.2011.02458.x","volume":"41","author":"H Moore","year":"2011","unstructured":"Moore H, Romeril K: Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib. Intern Med J. 2011, 41 (4): 348-350. 10.1111\/j.1445-5994.2011.02458.x. doi:10.1111\/j.1445-5994.2011.02458.x","journal-title":"Intern Med J"},{"issue":"2","key":"846_CR17","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/hr.2012.e13","volume":"4","author":"U Salmenniemi","year":"2012","unstructured":"Salmenniemi U, Remes K: Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma. Hematol Rep. 2012, 4 (2): e13-doi:10.4081\/hr.2012.e13","journal-title":"Hematol Rep"},{"key":"846_CR18","first-page":"bcr2012006461","volume-title":"BMJ Case Rep","author":"N Mehta","year":"2012","unstructured":"Mehta N, Saxena A, Niesvizky R: Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ Case Rep. 2012, bcr2012006461-doi:10.1136\/bcr-2012-006461"},{"issue":"4","key":"846_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc780","volume":"2","author":"M Karin","year":"2002","unstructured":"Karin M, Cao Y, Greten FR, Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002, 2 (4): 301-310. 10.1038\/nrc780.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"846_CR20","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","volume":"45","author":"J Usui","year":"2014","unstructured":"Usui J, Glezerman IG, Salvatore SP, Chandran CB, Flombaum CD, Seshan SV: Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature. Hum Pathol. 2014, 45 (9): 1918-1927. 10.1016\/j.humpath.2014.05.015. doi:10.1016\/j.humpath.2014.05.015. Epub 2014 Jun 12","journal-title":"Hum Pathol"},{"issue":"2","key":"846_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ndt\/gft465","volume":"29","author":"C Vigneau","year":"2014","unstructured":"Vigneau C, Lorcy N, Dolley-Hitze T, Jouan F, Arlot-Bonnemains Y, Laguerre B, Verhoest G, Goujon JM, Belaud-Rotureau MA, Rioux-Leclercq N: All anti-vascular endothelial growth factor drugs can induce \u2018pre-eclampsia-like syndrome\u2019: a RARe study. Nephrol Dial Transplant. 2014, 29 (2): 325-332. 10.1093\/ndt\/gft465. doi:10.1093\/ndt\/gft465. Epub 2013 Dec 2","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"846_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.beha.2007.09.003","volume":"20","author":"MV Mateos","year":"2007","unstructured":"Mateos MV, San Miguel JF: Bortezomib in multiple myeloma. Best Pract Res Clin Haematol. 2007, 20 (4): 701-715. 10.1016\/j.beha.2007.09.003.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"846_CR23","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/01.ATV.17.11.2793","volume":"17","author":"JR Horowitz","year":"1997","unstructured":"Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof DD, Chaudhry GM, Symes JF, Isner JM: Vascular endothelial growth factor\/vascular permeability factor produces nitric oxide-dependent hypotension: evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol. 1997, 17 (11): 2793-2800. 10.1161\/01.ATV.17.11.2793.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"846_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.semnephrol.2010.09.007","volume":"30","author":"ES Robinson","year":"2010","unstructured":"Robinson ES, Khankin EV, Karumanchi SA, Humphreys BD: Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker. Semin Nephrol. 2010, 30 (6): 591-601. 10.1016\/j.semnephrol.2010.09.007. doi:10.1016\/j.semnephrol.2010.09.007","journal-title":"Semin Nephrol"},{"issue":"5","key":"846_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3346\/jkms.2014.29.5.648","volume":"29","author":"KS Yang","year":"2014","unstructured":"Yang KS, Jeon H, Park Y, Jo IH, Kim JI, Moon IS, Choi BS, Park CW, Yang CW, Kim YS, Chung BH: Use of bortezomib as anti-humoral therapy in kidney transplantation. J Korean Med Sci. 2014, 29 (5): 648-651. 10.3346\/jkms.2014.29.5.648. doi:10.3346\/jkms.2014.29.5.648. Epub 2014 Apr 25","journal-title":"J Korean Med Sci"},{"issue":"5","key":"846_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/petr.12300","volume":"18","author":"MD Zinn","year":"2014","unstructured":"Zinn MD, L\u2019Ecuyer TJ, Fagoaga OR, Aggarwal S: Bortezomib use in a pediatric cardiac transplant center. Pediatr Transplant. 2014, 18 (5): 469-476. 10.1111\/petr.12300. doi:10.1111\/petr.12300. Epub 2014 Jun 14. PMID: 24931171[PubMed - in process]","journal-title":"Pediatr Transplant"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1745-6215-15-107","volume":"15","author":"F Eskandary","year":"2014","unstructured":"Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, B\u00f6hmig GA: Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Trials. 2014, 15: 107-10.1186\/1745-6215-15-107. doi:10.1186\/1745-6215-15-107","journal-title":"Trials"},{"issue":"13","key":"846_CR28","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","volume":"67","author":"SD Demo","year":"2007","unstructured":"Demo SD, Kirk CJ, Aujay MA, Buchholz TJ, Dajee M, Ho MN, Jiang J, Laidig GJ, Lewis ER, Parlati F, Shenk KD, Smyth MS, Sun CM, Vallone MK, Woo TM, Molineaux CJ, Bennett MK: Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. Cancer Res. 2007, 67 (13): 6383-6391. 10.1158\/0008-5472.CAN-06-4086.","journal-title":"Cancer Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-15-156\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-15-156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T10:19:03Z","timestamp":1650277143000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-15-156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-15-156","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]},"assertion":[{"value":"8 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"156"}}